Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Spero Therapeutics, Inc. (SPRO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/24/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/14/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/14/2022 |
3
| HAMED KAMAL (Chief Medical Officer) has filed a Form 3 on Spero Therapeutics, Inc. |
| 10/14/2021 |
3
| Tregoning Kathleen (Director) has filed a Form 3 on Spero Therapeutics, Inc. |
| 01/05/2021 |
3
| Shukla Sath (CFO) has filed a Form 3 on Spero Therapeutics, Inc. |
| 12/02/2020 |
3
| JOSEPH TAMARA L (Chief Legal Officer) has filed a Form 3 on Spero Therapeutics, Inc. |
| 09/22/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/23/2020 |
3
| Jackson Scott Thomas (Director) has filed a Form 3 on Spero Therapeutics, Inc. |
| 01/13/2020 |
3
| Keutzer Timothy (Chief Development Officer) has filed a Form 3 on Spero Therapeutics, Inc. |
| 11/08/2019 |
3
| DiPalma Stephen J. (Interim CFO) has filed a Form 3 on Spero Therapeutics, Inc. |
| 03/19/2019 |
3
| Smith Cynthia (Director) has filed a Form 3 on Spero Therapeutics, Inc. |
| 09/21/2018 |
3
| Pottage John C Jr (Director) has filed a Form 3 on Spero Therapeutics, Inc. |
| 02/06/2018 |
3
| SOUTHWELL DAVID P (Director) has filed a Form 3 on Spero Therapeutics, Inc. |
| 01/05/2018 |
3
| Melnick David A. (Chief Medical Officer) has filed a Form 3 on Spero Therapeutics, Inc. |
| 11/02/2017 |
3
| GLAXOSMITHKLINE PLC (10% Owner) has filed a Form 3 on Spero Therapeutics, Inc. |
| 11/01/2017 |
3
| Halse Reza (Director) has filed a Form 3 on Spero Therapeutics, Inc. |
| 11/01/2017 |
3
| Sendek Joel (CFO) has filed a Form 3 on Spero Therapeutics, Inc. |
| 11/01/2017 |
3
| Breum Casper (Director) has filed a Form 3 on Spero Therapeutics, Inc. |
| 11/01/2017 |
3
| Atlas Venture Fund IX, L.P. (10% Owner) has filed a Form 3 on Spero Therapeutics, Inc. |
| 11/01/2017 |
3
| Parr Thomas R JR (Chief Scientific Officer) has filed a Form 3 on Spero Therapeutics, Inc. |
| 11/01/2017 |
3
| THOMAS FRANK E (Director) has filed a Form 3 on Spero Therapeutics, Inc. |
| 11/01/2017 |
3
| Lundbeckfond Invest A/S (10% Owner) has filed a Form 3 on Spero Therapeutics, Inc. |
| 11/01/2017 |
3
| Larkin Cristina (COO) has filed a Form 3 on Spero Therapeutics, Inc. |
| 11/01/2017 |
3
| FORMELA JEAN FRANCOIS (Director) has filed a Form 3 on Spero Therapeutics, Inc. |
| 11/01/2017 |
3
| VINK PATRICK V.J.J. (Director) has filed a Form 3 on Spero Therapeutics, Inc. |
| 11/01/2017 |
3
| Deshpande Milind (Director) has filed a Form 3 on Spero Therapeutics, Inc. |
| 11/01/2017 |
3
| Mahadevia Ankit (See Remarks) has filed a Form 3 on Spero Therapeutics, Inc. |
| 11/01/2017 |
3
| Goyal Vikas (Director) has filed a Form 3 on Spero Therapeutics, Inc. |
| 11/01/2017 |
3
| GV 2015 GP, L.L.C. (10% Owner) has filed a Form 3 on Spero Therapeutics, Inc. |
|
|